Horizon 2020 Health

SC1-BHC-21-2018: Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation

Deadline: April 18, 2018

ECDC (European Centre for Disease Control) and WHO-Europe (World Health Organisation) report high number of cases for HIV and TB infections (both in incidence and prevalence) in the European regions and in recent years the epidemic situation has deteriorated in Eastern Europe.

Proposals should address one of more of three different subtopics. In performing the research agenda to address one (or more) of the subtopics, the applicants might make use of already established European cohort networks or establish new collaborations thus widening their geographical scope and include HIV, HCV and/or TB mono or co-infected individuals and perform retrospective or prospective studies.

Funds projects within:

The official call from Horizon 2020 Health

Can your project get funding from Horizon 2020 Health

Is this call a perfect match for your project? Contact us to discuss your possibilities within Horizon 2020 Health.

About Horizon 2020 Health

With support from Horizon 2020 Health you will be able to conduct international research projects in support of EU policies for health. Support will be given to projects aimed at: Health promotion and prevention; diagnosis improvement; innovative treatments and technologies; active and healthy aging; citizen-centered care; and improving health information etc.

More about the grant

We help you succeed

We help companies obtain public funding by converting good projects to well-prepared applications.

Our services cover the entire application process:

Identifying funding opportunities
We identifying your best funding opportunities
Planning and scoping your project
We plan and scope your project to meet demands
Writing the successful application
We write the application that increases your chance of success